SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy. Winer L, Srinivasan D, Chun S, Lacomis D, Jaffa M, Fagan A, Holtzman DM, Wancewicz E, Bennett FC, Bowser R, et al. Arch Neurol. 2012 Nov 12:1-7. PMID: 23147550. Abstract CommentRecommendBookmarkWatch